📰 Dermavant Sciences News
Page 4 - Dermavant Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dermavant Sciences. Real-time updates on events, politics, business and more.
January 12, 2023
- Seven posters will include clinical data for VTAMA cream for the treatment of plaque psoriasis in adults and atopic dermatitis (AD), including data from the successful pediatric maximum usage study
December 8, 2022
/PRNewswire/ -- The "Atopic Dermatitis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027" report has been added to...
November 22, 2022
/PRNewswire/ -- According to Ariztons latest research report, the atopic dermatitis treatment market is expected to reach USD 11.34 billion by 2027. The most...
November 22, 2022
CHICAGO, Nov. 22, 2022 /PRNewswire/ -- According to Arizton's latest research report, the atopic dermatitis treatment market is expected to reach USD 11.34 billion by 2027. The most common type
November 22, 2022
/PRNewswire/ -- According to Ariztons latest research report, the atopic dermatitis treatment market is expected to reach USD 11.34 billion by 2027. The most...
November 9, 2022
New York, NY (PRWEB) November 09, 2022 -- The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Los Angeles for
November 2, 2022
New York, NY (PRWEB) November 02, 2022 -- The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of San Francisco
October 13, 2022
- Five posters will highlight clinical data for VTAMA cream for the treatment of plaque psoriasis in adults and for atopic dermatitis in patients as young as two - Dermavant Sciences, a biopharmaceutical
September 28, 2022
New York, NY (PRWEB) September 28, 2022 -- The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Dallas for
September 7, 2022
The awards mark Dermavant's fourth and fifth recognitions by Fortune and Great Place to Work Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics